Skip to content

Post traumatic stress disorder and neurons degeneration, stress leading to accelerated aging.

Post traumatic stress disorder and neuroprogression. Trauma and stress increasing alostatic load and accelerating the aging process.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3z474z
Enrollment
Unknown
Registered
2017-09-28
Start date
2015-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post traumatic stress disorder

Interventions

120 women raped in the last six months with a confirmed diagnosis of post traumatic stress disorder will be included. They will be randomized in two groups, one will receive sertraline between 50 and
Drug
Behavioural

Sponsors

Escola Paulista de Medicina
Lead Sponsor
Departamento de psiquiatria da Universidade Federal de São Paulo
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women; between 18-45 years old; raped in the last six months; evaluated at Perola Byington Hospital specialized service; with post traumatic stress disorder.

Exclusion criteria

Exclusion criteria: Menopause; mental retardation; clinical and neurological diseases not under control; schizophrenia; bipolar disorder; drug or alcohol dependence.

Design outcomes

Primary

MeasureTime frame
Scores of the Clinical Global Impression (CGI) scale at every visit. The scale points are from 0=no symptoms to 7=extremely worse. Measured at 2, 4, 8 and 14 weeks. It is expected that patients could improve in both treatment arms, with a score reduction of at least 2 points.;Improvement of PTSD symptoms measured by the CAPS scale. The scale has 30 itens that adresses 20 PTSD symptoms. Itens are scored as 0=no symptom to 4=severe symptom. A 50% reduction of symptomatology is expected.

Secondary

MeasureTime frame
Beck depression (BDI) and Anxiety (BAI)inventories are self report scales that will be applied to evaluate associated symptoms of anxiety and depression. Both scales scores are from 0-63 points. For BDI mild depression is considered up to 10 points and up to 20 severe depression. For BAI up to 8 is mild anxiety and up to 26 is severe anxiety. Symptomatology is expected to decrease with the treatment with a 50% score reduction.

Countries

Brazil

Contacts

Public ContactMarcelo de Mello

Universidade Federal de Sao Paulo-Depto de Psiquiatria

feijomellom@me.com+55 (11) 55764991

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 17, 2026